Sun Pharma Advanced Research Company Ltd Q2 FY2024-2025 Results: Summary
Revenue | ₹12.90Cr |
Net Profits | ₹-107.33Cr |
Net Profit Margins | -832.02% |
Sun Pharma Advanced Research Company Ltd’s revenue fell -56.52% since last year same period to ₹12.90Cr in the Q2 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -29.78% fall in its revenue since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit fell -24.2% since last year same period to ₹-107.33Cr in the Q2 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -11.92% fall in its net profits since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit margin fell -185.65% since last year same period to -832.02% in the Q2 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -59.38% fall in its net profit margins since last 3-months.
